Cargando…

Berry Extracts and Their Bioactive Compounds Mitigate LPS and DNFB-Mediated Dendritic Cell Activation and Induction of Antigen Specific T-Cell Effector Responses

Berries have gained widespread recognition for their abundant natural antioxidant, anti-inflammatory, and immunomodulatory properties. However, there has been limited research conducted thus far to investigate the role of the active constituents of berries in alleviating contact hypersensitivity (CH...

Descripción completa

Detalles Bibliográficos
Autores principales: Upadhaya, Puja, Lamenza, Felipe F., Shrestha, Suvekshya, Roth, Peyton, Jagadeesha, Sushmitha, Pracha, Hasan, Horn, Natalie A., Oghumu, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525528/
https://www.ncbi.nlm.nih.gov/pubmed/37759970
http://dx.doi.org/10.3390/antiox12091667
_version_ 1785110805999517696
author Upadhaya, Puja
Lamenza, Felipe F.
Shrestha, Suvekshya
Roth, Peyton
Jagadeesha, Sushmitha
Pracha, Hasan
Horn, Natalie A.
Oghumu, Steve
author_facet Upadhaya, Puja
Lamenza, Felipe F.
Shrestha, Suvekshya
Roth, Peyton
Jagadeesha, Sushmitha
Pracha, Hasan
Horn, Natalie A.
Oghumu, Steve
author_sort Upadhaya, Puja
collection PubMed
description Berries have gained widespread recognition for their abundant natural antioxidant, anti-inflammatory, and immunomodulatory properties. However, there has been limited research conducted thus far to investigate the role of the active constituents of berries in alleviating contact hypersensitivity (CHS), the most prevalent occupational dermatological disease. Our study involved an ex vivo investigation aimed at evaluating the impact of black raspberry extract (BRB-E) and various natural compounds found in berries, such as protocatechuic acid (PCA), proanthocyanidins (PANT), ellagic acid (EA), and kaempferol (KMP), on mitigating the pathogenicity of CHS. We examined the efficacy of these natural compounds on the activation of dendritic cells (DCs) triggered by 2,4-dinitrofluorobenzene (DNFB) and lipopolysaccharide (LPS). Specifically, we measured the expression of activation markers CD40, CD80, CD83, and CD86 and the production of proinflammatory cytokines, including Interleukin (IL)-12, IL-6, TNF-α, and IL-10, to gain further insights. Potential mechanisms through which these phytochemicals could alleviate CHS were also investigated by investigating the role of phospho-ERK. Subsequently, DCs were co-cultured with T-cells specific to the OVA(323-339) peptide to examine the specific T-cell effector responses resulting from these interactions. Our findings demonstrated that BRB-E, PCA, PANT, and EA, but not KMP, inhibited phosphorylation of ERK in LPS-activated DCs. At higher doses, EA significantly reduced expression of all the activation markers studied in DNFB- and LPS-stimulated DCs. All compounds tested reduced the level of IL-6 in DNFB-stimulated DCs in Flt3L as well as in GM-CSF-derived DCs. However, levels of IL-12 were reduced by all the tested compounds in LPS-stimulated Flt3L-derived BMDCs. PCA, PANT, EA, and KMP inhibited the activated DC-mediated Interferon (IFN)-γ and IL-17 production by T-cells. Interestingly, PANT, EA, and KMP significantly reduced T-cell proliferation and the associated IL-2 production. Our study provides evidence for differential effects of berry extracts and natural compounds on DNFB and LPS-activated DCs revealing potential novel approaches for mitigating CHS.
format Online
Article
Text
id pubmed-10525528
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105255282023-09-28 Berry Extracts and Their Bioactive Compounds Mitigate LPS and DNFB-Mediated Dendritic Cell Activation and Induction of Antigen Specific T-Cell Effector Responses Upadhaya, Puja Lamenza, Felipe F. Shrestha, Suvekshya Roth, Peyton Jagadeesha, Sushmitha Pracha, Hasan Horn, Natalie A. Oghumu, Steve Antioxidants (Basel) Article Berries have gained widespread recognition for their abundant natural antioxidant, anti-inflammatory, and immunomodulatory properties. However, there has been limited research conducted thus far to investigate the role of the active constituents of berries in alleviating contact hypersensitivity (CHS), the most prevalent occupational dermatological disease. Our study involved an ex vivo investigation aimed at evaluating the impact of black raspberry extract (BRB-E) and various natural compounds found in berries, such as protocatechuic acid (PCA), proanthocyanidins (PANT), ellagic acid (EA), and kaempferol (KMP), on mitigating the pathogenicity of CHS. We examined the efficacy of these natural compounds on the activation of dendritic cells (DCs) triggered by 2,4-dinitrofluorobenzene (DNFB) and lipopolysaccharide (LPS). Specifically, we measured the expression of activation markers CD40, CD80, CD83, and CD86 and the production of proinflammatory cytokines, including Interleukin (IL)-12, IL-6, TNF-α, and IL-10, to gain further insights. Potential mechanisms through which these phytochemicals could alleviate CHS were also investigated by investigating the role of phospho-ERK. Subsequently, DCs were co-cultured with T-cells specific to the OVA(323-339) peptide to examine the specific T-cell effector responses resulting from these interactions. Our findings demonstrated that BRB-E, PCA, PANT, and EA, but not KMP, inhibited phosphorylation of ERK in LPS-activated DCs. At higher doses, EA significantly reduced expression of all the activation markers studied in DNFB- and LPS-stimulated DCs. All compounds tested reduced the level of IL-6 in DNFB-stimulated DCs in Flt3L as well as in GM-CSF-derived DCs. However, levels of IL-12 were reduced by all the tested compounds in LPS-stimulated Flt3L-derived BMDCs. PCA, PANT, EA, and KMP inhibited the activated DC-mediated Interferon (IFN)-γ and IL-17 production by T-cells. Interestingly, PANT, EA, and KMP significantly reduced T-cell proliferation and the associated IL-2 production. Our study provides evidence for differential effects of berry extracts and natural compounds on DNFB and LPS-activated DCs revealing potential novel approaches for mitigating CHS. MDPI 2023-08-24 /pmc/articles/PMC10525528/ /pubmed/37759970 http://dx.doi.org/10.3390/antiox12091667 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Upadhaya, Puja
Lamenza, Felipe F.
Shrestha, Suvekshya
Roth, Peyton
Jagadeesha, Sushmitha
Pracha, Hasan
Horn, Natalie A.
Oghumu, Steve
Berry Extracts and Their Bioactive Compounds Mitigate LPS and DNFB-Mediated Dendritic Cell Activation and Induction of Antigen Specific T-Cell Effector Responses
title Berry Extracts and Their Bioactive Compounds Mitigate LPS and DNFB-Mediated Dendritic Cell Activation and Induction of Antigen Specific T-Cell Effector Responses
title_full Berry Extracts and Their Bioactive Compounds Mitigate LPS and DNFB-Mediated Dendritic Cell Activation and Induction of Antigen Specific T-Cell Effector Responses
title_fullStr Berry Extracts and Their Bioactive Compounds Mitigate LPS and DNFB-Mediated Dendritic Cell Activation and Induction of Antigen Specific T-Cell Effector Responses
title_full_unstemmed Berry Extracts and Their Bioactive Compounds Mitigate LPS and DNFB-Mediated Dendritic Cell Activation and Induction of Antigen Specific T-Cell Effector Responses
title_short Berry Extracts and Their Bioactive Compounds Mitigate LPS and DNFB-Mediated Dendritic Cell Activation and Induction of Antigen Specific T-Cell Effector Responses
title_sort berry extracts and their bioactive compounds mitigate lps and dnfb-mediated dendritic cell activation and induction of antigen specific t-cell effector responses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525528/
https://www.ncbi.nlm.nih.gov/pubmed/37759970
http://dx.doi.org/10.3390/antiox12091667
work_keys_str_mv AT upadhayapuja berryextractsandtheirbioactivecompoundsmitigatelpsanddnfbmediateddendriticcellactivationandinductionofantigenspecifictcelleffectorresponses
AT lamenzafelipef berryextractsandtheirbioactivecompoundsmitigatelpsanddnfbmediateddendriticcellactivationandinductionofantigenspecifictcelleffectorresponses
AT shresthasuvekshya berryextractsandtheirbioactivecompoundsmitigatelpsanddnfbmediateddendriticcellactivationandinductionofantigenspecifictcelleffectorresponses
AT rothpeyton berryextractsandtheirbioactivecompoundsmitigatelpsanddnfbmediateddendriticcellactivationandinductionofantigenspecifictcelleffectorresponses
AT jagadeeshasushmitha berryextractsandtheirbioactivecompoundsmitigatelpsanddnfbmediateddendriticcellactivationandinductionofantigenspecifictcelleffectorresponses
AT prachahasan berryextractsandtheirbioactivecompoundsmitigatelpsanddnfbmediateddendriticcellactivationandinductionofantigenspecifictcelleffectorresponses
AT hornnataliea berryextractsandtheirbioactivecompoundsmitigatelpsanddnfbmediateddendriticcellactivationandinductionofantigenspecifictcelleffectorresponses
AT oghumusteve berryextractsandtheirbioactivecompoundsmitigatelpsanddnfbmediateddendriticcellactivationandinductionofantigenspecifictcelleffectorresponses